--------------
Just a brief review of FY2011 audited financials released tonight:
Annual Revenue: $11.2M. Doubled Revenue Quarter over Quarter, and year over year.
Q Revenue was almost $6M ($5.55).
Cash on hand was $14M at FY2011 end.
Revenue for first 9 months: $5.65M, as per below, so Q4 revenue was $5.55M.
Operating Revenue Q3: 2,537 Q2: 1,217 Q1: 1,900
Net loss is $10M, $5.5 of which is stock based compensation, 900k is write down of Sawayardun - which could/should still be paid to them. Overall, I am pleased as rev was over $5M...
They have cleaned up the balance sheet to allow for a very positive FY 2012, in my view.
Also, stockpiles of $2.6M carried over into 2012... we may we see this in Q1...
Q1 due out by the EO February should be very interesting...
Recent MJS News
- TSX Venture Exchange Stock Maintenance Bulletins • PR Newswire (Canada) • 12/29/2023 01:22:00 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM